U.S. Brand Names:
Cordran®; Cordran® SP
Synonyms:
Flurandrenolone
Generic Available:
No
Canadian Brand Names:
Cordran®
Use:
Inflammation of corticosteroid-responsive dermatoses [medium potency topical corticosteroid]
Pregnancy Risk Factor:
C
Contraindications:
Hypersensitivity to flurandrenolide or any component of the formulation; viral, fungal, or tubercular skin lesions
Warnings/Precautions:
Adverse systemic effects may occur when used on large areas of the body, denuded areas, for prolonged periods of time, with an occlusive dressing, and/or in infants or small children
Adverse Reactions:
Frequency not defined.
Cardiovascular: Intracranial hypertension
Dermatologic: Itching, dry skin, folliculitis, hypertrichosis, acneiform eruptions, hyperpigmentation, perioral dermatitis, allergic contact dermatitis, skin atrophy, striae, miliaria, acne, maceration of the skin
Endocrine & metabolic: Cushing's syndrome, growth retardation, HPA suppression
Local: Burning, irritation
Miscellaneous: Secondary infection
Overdosage/Toxicology:
When consumed in excessive quantities, systemic hypercorticism and adrenal suppression may occur; in those cases, discontinuation and withdrawal of the corticosteroid should be done judiciously
Drug Interactions:
No data reported
Mechanism of Action:
Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability
Pharmacodynamics/Kinetics:
Absorption: Adequate with intact skin; repeated applications lead to depot effects on skin, potentially resulting in enhanced percutaneous absorption
Metabolism: Hepatic
Excretion: Urine; feces (small amounts)
Dosage:
Topical: Therapy should be discontinued when control is achieved; if no improvement is seen, reassessment of diagnosis may be necessary.
Children:
Ointment, cream: Apply sparingly 1-2 times/day
Tape: Apply once daily
Adults: Cream, lotion, ointment: Apply sparingly 2-3 times/day
Administration:
Avoid contact with eyes. Apply sparingly in a light film and rub in lightly. A thin film is effective; do not overuse. Do not use tight-fitting diapers or plastic pants on children being treated in the diaper area.
Patient Education:
A thin film is effective; do not overuse. Do not use tight-fitting diapers or plastic pants on children being treated in the diaper area. Use only as prescribed, and for no longer than the period prescribed. Apply sparingly in a light film and rub in lightly. Avoid contact with eyes. Notify physician if condition being treated persists or worsens. Pregnancy precaution: Inform prescriber if you are pregnant.
Dental Health: Effects on Dental Treatment:
No significant effects or complications reported
Dental Health: Vasoconstrictor/Local Anesthetic Precautions:
No information available to require special precautions
Dosage Forms:
Cream, emulsified, as base (Cordran® SP): 0.025% (30 g, 60 g); 0.05% (15 g, 30 g, 60 g)
Lotion (Cordran®): 0.05% (15 mL, 60 mL)
Ointment (Cordran®): 0.025% (30 g, 60 g); 0.05% (15 g, 30 g, 60 g)
Tape, topical [roll] (Cordran®): 4 mcg/cm2 (7.5 cm x 60 cm, 7.5 cm x 200 cm)
International Brand Names:
Cordran® (CA)